<DOC>
	<DOCNO>NCT02147561</DOCNO>
	<brief_summary>This study evaluate safety efficacy BOTOX® treatment Korean adult chronic migraine .</brief_summary>
	<brief_title>A Safety Efficacy Study BOTOX® Korean Adults With Chronic Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Ethnically Korean diagnosis chronic migraine Anticipated need botulinum toxin treatment reason chronic migraine study Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>